Innofactor’s Q4 results were below our expectations.
Solteq’s Q4 was below our lowered pre-Q4 expectations, with revenue at EUR 18.
Raketech reported a solid Q4 overall, with revenues 4% below our expectations, whereas adjusted EBIT...
A particularly good shipping market was the main reason for Aspo's clear EBIT beat versus market con...
Redeye states that the Q4 report was weaker than expected and that customer projects will be delayed...
Redeye was surprised by QleanAir’s Q4 report in terms of growth but was left a bit disappointed on t...
Redeye is surprised to see another quarter of exceptional growth.
Redeye's preliminary revisions suggest a small increase in our sales forecast while leaving EBIT lar...
Redeye provides an initial take on Arise’s Q4 report, where both sales and EBITDA grew impressively ...
Redeye provides a comment on Gapwaves' year-end report.
Redeye's first impressions on the Q4 report from Bioservo earlier this morning.
Redeye shares its initial take on Stille’s Q4’21 report, which came in slightly below our expectatio...
Redeye will likely lower its fair value range after the sales miss in the year-end report.
Waystream reported their Q4 numbers earlier this morning.
Redeye provides its initial take on BONESUPPORT’s Q4 report and expects a positive reaction of c.
Q-linea's partner Thermo Fisher is launching ASTar in Europe, and Q4 is the first quarter featuring ...
Redeye comments on the Q3-report from Embracer. Operational EBIT was almost exactly as we had estima...
Redeye states that the Q4 report was rock-solid with much higher profitability than we had estimated...
MOBA delivered a strong report, Sales were 18% ahead of our expectations while EBIT was 14% ahead.
Redeye will likely make slight estimate changes on the back of Artificial Solutions' year-end report...
